Evidence map›Paper›PMID 37375656›Full record

Trial reportNutrients2023

Oligomalt, a New Slowly Digestible Carbohydrate, Is Well Tolerated in Healthy Young Men and Women at Intakes Up to 180 Gram per Day: A Randomized, Double-Blind, Crossover Trial.

Odd Erik Johansen, Delphine Curti, Maximilian von Eynatten, Andreas Rytz, Anirban Lahiry, Frederik Delodder, Gerhard Ufheil, Carmine D'Urzo, Audrey Orengo, Kate Thorne and 1 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05142137 (Randomised, Placebo-controlled Chronic Study to Investigate Gastrointestinal Tolerability of a Novel Alpha Glucan in Adults), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05142137 nacompletednot on this map

Randomised, Placebo-controlled Chronic Study to Investigate Gastrointestinal Tolerability of a Novel Alpha Glucan in Adults

TypeinterventionalSponsorSociété des Produits Nestlé (SPN)Ran2021 to 2021Enrolled24ConditionsHealthy VolunteersArmsDrinkable solution
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Odd Erik JohansenNestlé Health Science, 1000 Lausanne, Switzerland.ORCID 0000-0003-2470-0530
Delphine CurtiSociété des Produits Nestlé, 1000 Lausanne, Switzerland.
Maximilian von EynattenNestlé Health Science, 1000 Lausanne, Switzerland.
Andreas RytzNestlé Research, Clinical Research Unit, 1000 Lausanne, Switzerland.ORCID 0000-0001-5992-9154
Anirban LahiryNestlé Research, Clinical Research Unit, 1000 Lausanne, Switzerland.ORCID 0009-0008-9191-0136
Frederik DelodderNestlé Research, Clinical Research Unit, 1000 Lausanne, Switzerland.
Gerhard UfheilNestlé Research and Development Konolfingen, Société des Produits Nestlé S.A., 3510 Konolfingen, Switzerland.
Carmine D'UrzoNestlé Health Science, 1000 Lausanne, Switzerland.
Audrey OrengoSociété des Produits Nestlé, 1000 Lausanne, Switzerland.
Kate ThorneNestlé Health Science, 1000 Lausanne, Switzerland.
Jaclyn S Lerea-AntesNestlé Product Technology Center NHS, Société des Produits Nestlé S.A., Bridgewater, NJ 08807, USA.
Nestlé (Switzerland) · CHNestlé Health Science (United States)

Funding

Nestlé Health Science, Vevey, Switzerland N/A
6 · The paper itself

Abstract

In this randomized, double-blind triple-crossover study (NCT05142137), the digestive tolerance and safety of a novel, slowly digestible carbohydrate (SDC), oligomalt, an α-1,3/α-1,6-glucan α-glucose-based polymer, was assessed in healthy adults over three separate 7-day periods, comparing a high dose of oligomalt (180 g/day) or a moderate dose of oligomalt (80 g/day in combination with 100 g maltodextrin/day) with maltodextrin (180 g/day), provided as four daily servings in 300 mL of water with a meal. Each period was followed by a one-week washout. A total of 24 subjects (15 females, age 34 years, BMI 22.2 kg/m

Indexed as

Gastrointestinal DiseasesAbdominal PainAdultCross-Over StudiesDouble-Blind MethodFemaleGlucansHumansMaleYoung AdultGlucansclinical trialdietary carbohydratefoodgastrointestinal tolerance

Identifiers

PMID37375656
PMCPMC10305601
OpenAlexW4380995662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.